There was no reason given for Seshadri’s departure. He joined the company in 2006 and helped navigate some tough times when it was under-performing, Smiths said.
McCaulley comes to the company after running Zimmer’s reconstructive division for the past 5 years. The 25-year medical device industry veteran has also worked for Wolters Kluwer Health Inc., Medtronic (NYSE:MDT) and GE Healthcare (NYSE:GE), according to a press release.
“I am delighted to welcome Jeff into the Smiths family of businesses. His knowledge of the sector, outstanding track record in improving business performance and focus on customer-driven product development ideally equip him to lead Smiths Medical in the next stage of its development,” Smiths Group CEO Philip Bowman said in prepared remarks.
Stereotaxis promotes interim CEO to full-time job
Stereotaxis (NSDQ:STXS) named interim CEO & chairman William Mills to official position of CEO. Mills has been with the company since 2000, becoming chairman in 2012.
Ingen Technologies names new CEO
Ingen Technologies (OTC:IGNT) named David Hanson its new CEO. Hanson will take over for Thomas Neavitt, who is retiring after being with the company for 10 years.
Smith & Nephew directors to step down
Smith & Nephew (FTSE:SN, NYSE:SNN) senior independent director Richard De Schutter and non-executive director Ajay Piramal are stepping down from the board, effective this April. Brian Larcombe is expected to take over as the senior independent director in De Schutter’s place.
ProUroCare director resigns, plans investment group
ProUroCare Medical (OTC:PUMD) board member Robert Rudelius stepped down. Rudelius is organizing an investment group in order to make a significant contribution to the company.